Skip Nav Destination
Close
Article navigation
Education|
December 1988
Plasma Levels of Dantrolene following Oral Administration in Malignant Hyperthermia-susceptible Patients
Gregory C. Allen, M.D., F.R.C.P.C.
;
Gregory C. Allen, M.D., F.R.C.P.C.
*Resident in Anesthesia.
Search for other works by this author on:
Charles B. Cattran, M.D., F.R.C.P.C
;
Charles B. Cattran, M.D., F.R.C.P.C
†Clinical Lecturer in Anesthesia.
Search for other works by this author on:
Robert G. Peterson, M.D., Ph.D.
;
Robert G. Peterson, M.D., Ph.D.
‡Associate Professor of Pediatrics and Pharmacology.
Search for other works by this author on:
Marcel Lalande, Ph.D.
Marcel Lalande, Ph.D.
§Post-doctoral Pharmacology Fellow, Department of Pediatrics.
Search for other works by this author on:
Anesthesiology December 1988, Vol. 69, 900–904.
Citation
Gregory C. Allen, Charles B. Cattran, Robert G. Peterson, Marcel Lalande; Plasma Levels of Dantrolene following Oral Administration in Malignant Hyperthermia-susceptible Patients. Anesthesiology 1988; 69:900–904 doi: https://doi.org/10.1097/00000542-198812000-00016
Download citation file:
Close
Citing articles via
Most Viewed
Related Articles
Cost-benefit Analysis of Maintaining a Fully Stocked Malignant Hyperthermia Cart versus an Initial Dantrolene Treatment Dose for Maternity Units
Anesthesiology (August 2018)
Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review
Anesthesiology (January 2019)
Cost-effectiveness Analysis of Stocking Dantrolene in Ambulatory Surgery Centers for the Treatment of Malignant Hyperthermia
Anesthesiology (June 2014)
Hemodynamic and Metabolic Manifestations of Acute Endotoxin Infusion in Pigs with and without the Malignant Hyperthermia Mutation
Anesthesiology (September 1999)
Malignant Hyperthermia Testing in Probands without Adverse Anesthetic Reaction
Anesthesiology (September 2015)
